Found: 1178
Select item for more details and to access through your institution.
SARS-CoV-2 Variants from Long-Term, Persistently Infected Immunocompromised Patients Have Altered Syncytia Formation, Temperature-Dependent Replication, and Serum Neutralizing Antibody Escape.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 9, p. 1436, doi. 10.3390/v16091436
- By:
- Publication type:
- Article
Exploring passive immunization therapies for COVID‐19 management in rheumatic patients.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 9, p. 1, doi. 10.1111/1756-185X.15325
- By:
- Publication type:
- Article
Studying the Humoral Response against SARS‐CoV‐2 in Cuban COVID‐19 Recovered Patients.
- Published in:
- Journal of Immunology Research, 2024, p. 1, doi. 10.1155/2024/7112940
- By:
- Publication type:
- Article
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1448720
- By:
- Publication type:
- Article
MSC–extracellular vesicle microRNAs target host cell-entry receptors in COVID-19: in silico modeling for in vivo validation.
- Published in:
- Stem Cell Research & Therapy, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13287-024-03889-9
- By:
- Publication type:
- Article
Immunization against Medically Important Human Coronaviruses of Public Health Concern.
- Published in:
- Canadian Journal of Infectious Diseases & Medical Microbiology, 2024, v. 2024, p. 1, doi. 10.1155/2024/9952803
- By:
- Publication type:
- Article
Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2364, doi. 10.1093/jac/dkae237
- By:
- Publication type:
- Article
High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization.
- Published in:
- Microorganisms, 2024, v. 12, n. 8, p. 1503, doi. 10.3390/microorganisms12081503
- By:
- Publication type:
- Article
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 17/18, p. 931, doi. 10.1007/s00508-021-01922-y
- By:
- Publication type:
- Article
Identifying the Effective Factors in the Death of Patients Receiving Convalescent Plasma.
- Published in:
- Journal of Inflammatory Diseases, 2022, v. 25, n. 4, p. 211, doi. 10.32598/JID.25.4.7
- By:
- Publication type:
- Article
Neutralizing Antibodies against SARS‑CoV2.
- Published in:
- Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2024, v. 17, n. 1, p. 9, doi. 10.4103/mjdrdypu.mjdrdypu_819_22
- By:
- Publication type:
- Article
Convalescent Coronavirus Disease 2019 Plasma Donor Profile: A Tertiary Care Hospital‑based Study.
- Published in:
- Biomedical & Biotechnology Research Journal, 2023, v. 7, n. 3, p. 359, doi. 10.4103/bbrj.bbrj_102_23
- By:
- Publication type:
- Article
Serological Testing for COVID-19 Disease: Moving the Field of Serological Surveillance Forward.
- Published in:
- 2021
- Publication type:
- Editorial
COVID-19 after rituximab therapy in cSLE patients.
- Published in:
- Therapeutic Advances in Vaccines & Immunotherapy, 2023, v. 11, p. 1, doi. 10.1177/25151355231181242
- By:
- Publication type:
- Article
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00560-3
- By:
- Publication type:
- Article
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00389-2
- By:
- Publication type:
- Article
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00256-6
- By:
- Publication type:
- Article
Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer.
- Published in:
- Virus Evolution, 2022, v. 8, n. 1, p. 1, doi. 10.1093/ve/veac023
- By:
- Publication type:
- Article
Practical recommendations for the prevention and management of COVID-19 in low-income and middle-income settings: adapting clinical experience from the field.
- Published in:
- Family Medicine & Community Health, 2021, v. 9, n. 2, p. 1, doi. 10.1136/fmch-2021-000930
- By:
- Publication type:
- Article
Characteristics and Motivational Factors of Whole Blood and Convalescent Plasma Donors during the SARS-CoV-2 Pandemic in Israel.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 5, p. 589, doi. 10.3390/healthcare12050589
- By:
- Publication type:
- Article
Perceptions of Romanian Physicians on Lockdowns for COVID-19 Prevention.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 1, p. 95, doi. 10.3390/healthcare9010095
- By:
- Publication type:
- Article
Letter to the Editor: Convalescent Plasma: An Old Trick for the Treatment of COVID-19.
- Published in:
- Journal of Pediatrics Review, 2020, v. 8, n. 3, p. 209, doi. 10.32598/jpr.8.3.270.1
- By:
- Publication type:
- Article
COVID-19 Convalescent Plasma Therapy: Long-term Implications.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad686
- By:
- Publication type:
- Article
P2‐24: Ways to tackle the highly transmissible delta virus.
- Published in:
- Respirology, 2021, v. 26, p. 122, doi. 10.1111/resp.14150_120
- Publication type:
- Article
P2‐24: Ways to tackle the highly transmissible delta virus.
- Published in:
- Respirology, 2021, v. 26, p. 122, doi. 10.1111/resp.14150_120
- Publication type:
- Article
Contemporary narrative review of treatment options for COVID‐19.
- Published in:
- Respirology, 2021, v. 26, n. 8, p. 745, doi. 10.1111/resp.14106
- By:
- Publication type:
- Article
Letter from Indonesia.
- Published in:
- Respirology, 2020, v. 25, n. 12, p. 1328, doi. 10.1111/resp.13953
- By:
- Publication type:
- Article
Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 15, p. 1938, doi. 10.3390/cells12151938
- By:
- Publication type:
- Article
Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 3122, doi. 10.3390/cells11193122
- By:
- Publication type:
- Article
Pregnancy and COVID-19: pharmacologic considerations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1421516
- By:
- Publication type:
- Article
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dosedependent protection against SARS-CoV-2 replication and disease in hamsters.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1138629
- By:
- Publication type:
- Article
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1055457
- By:
- Publication type:
- Article
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1034379
- By:
- Publication type:
- Article
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1008438
- By:
- Publication type:
- Article
Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.975533
- By:
- Publication type:
- Article
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.968105
- By:
- Publication type:
- Article
Updates on convalescent plasma and monoclonal antibody therapies for infectious disease in patients with primary immunodeficiency.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1010072
- By:
- Publication type:
- Article
The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.964398
- By:
- Publication type:
- Article
SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.854952
- By:
- Publication type:
- Article
Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.901217
- By:
- Publication type:
- Article
Efficient and Sustainable Platform for Preparation of a High-Quality Immunoglobulin G as an Urgent Treatment Option During Emerging Virus Outbreaks.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.889736
- By:
- Publication type:
- Article
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.857481
- By:
- Publication type:
- Article
Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.824378
- By:
- Publication type:
- Article
Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.842643
- By:
- Publication type:
- Article
Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.839367
- By:
- Publication type:
- Article
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.773982
- By:
- Publication type:
- Article
Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.835770
- By:
- Publication type:
- Article
Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.821721
- By:
- Publication type:
- Article